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Abstracts 193research. He co-founded the Molecular Imaging North Competence Center
(MOIN CC) at the Christian-Albrechts-Universita¨t zu Kiel, a preclinical imag-
ing lab. At MOIN CC, multi modal imaging studies combining micro computed
tomography, high-field magnetic resonance imaging, high resolution ultra-
sound, fluorescence and bioluminescence imaging can be carried out to
study morphological, functional, cellular, and molecular processes in health
and disease and to assess therapeutic effects.
Dr. Glu¨er is the current president of the German Society for Osteology
(DGO), past president of the German Academy of Bone & Joint Sciences
(DAdorW) and President of the European Calcified Tissue Society. He has
published more than 175 original papers, 20 books and book chapters, and
holds 3 patents.OPPORTUNISTIC BONE DENSITY SCREENING BY DUAL-USE OF CT SCANS
Alan Brett, PhD
Mindways Software, Inc., USA
Central DXA of the lumbar spine and proximal femur is the preferred method
for bone mineral density (BMD) testing. Despite the fracture risk statistics,
osteoporosis testing with dual energy X-ray absorptiometry (DXA) remains
underused. However, BMD can also be assessed with other radiologic imaging
tools, such as quantitative computed tomography (QCT) that may be
available when access to DXA is restricted.
For patients undergoing screening CT colonography (CTC), a potential
opportunity exists for concurrent BMD screening by QCT without the need
for any additional imaging, radiation exposure, or patient time. In addition,
there are a number of indications for CT imaging for which there is a large
overlap between the need for a CT scan and a patient having risk factors for
osteoporosis. Use may also be made of these CT images for BMD measure-
ment by QCT. Such dual-use of CT images could increase screening rates or,
alternatively, preclude the need for DXA screening in some individuals.
Previous studies combining standard CT imaging and QCT have generally
focused on BMD measurement at the lumbar spine. QCT provides a volumetric
BMD measure of the trabecular vertebral bone in isolation. This can have an
advantage of superior sensitivity due to the higher turnover rate of trabecular
bone, but QCT T-scores are somewhat lower than DXA T-scores for the same
age and the established WHO classification of osteoporosis by DXA T-score is
not appropriate. In contrast, at the proximal femur, QCT 3D data may be used
to derive a projectional 2D image of the proximal femur and this imagemay be
analyzed using standard DXA ROIs to determine DXA-equivalent “CTXA” aBMD
values in g/cm2. Using this method, the WHO T-score classifications may be
applied and the aBMD measures may be included in FRAX calculations.
Theworkflowassociatedwith such dual-use of CTscansmaybe improved by the
use of phantomless or “asynchronous” calibration methods, so that the BMD
measurement does not need to be planned in advance of the CT scan. In
addition, using such methods, it is possible to make use of archived CT scans
retrospectively. Finally, the use of IV contrast-enhanced CT images for QCT is
usually contraindicated and a measurement bias has been shown at the spine.
However, some recent studies suggest that for measurements made at the hip,
themeasurementdifferencedue tocontrast enhancementmaynotbeclinically
significant, further widening the utility of CT scans for BMD measurement.
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ADVANCED vQCT AND HR-pQCT IN SCIENCE AND CLINICAL TRIALS
Klaus Engelke
Institute of Medical Physics, University of Erlangen, Germany
QCT is increasingly used for the analysis of clinical studies and of
epidemiology data. To date a number of different software options exist
for the analysis of QCT images. As a consequence, a multitude of parameters
related to bone mineral density, bone geometry and related to bone
strength can be obtained in various volumes of interest in the spine and
proximal femur. Many of them are highly correlated and appropriate analysis
strategies will be discussed. In addition a number of different algorithms
such as global or local adaptive thresholds using different criteria to segment
the cortex are in use to quantify parameters such as cortical BMD, BMC or
thickness. Strengths and weaknesses of the different approaches will be
discussed by comparing effects on accuracy errors of one-time measure-
ments and on accuracy errors of changes during longitudinal measurements.
In contrast to QCT, hr-pQCT measurements of the radius and tibia are more
standardized as only the XtremeCT scanner is available for hr-pQCT
measurements in humans. But also for this scanner different algorithms to
assess the cortex exist and a newer version, which allows for faster scan
times and slightly higher spatial resolution has been introduced recently.
The lecture will review recent use of QCT using whole body CT scanners and
of hr-pQCT to predict or discriminate hip fracture and to monitor age related
changes or treatment efficacy in recent clinical trials in osteoporosis. It will
include a brief introduction to advanced QCT methodology. Learning
objectives are to understand what is measured by QCT, what are the
advantages of QCT and hr-pQCT (in particular compared to DXA) and what
potential pitfalls exist in the interpretation of QCT and hr-pQCT parameters.
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Hamburg, Germany in 1989 for his pioneering work in mCT using Synchrotron
Radiation. Afterwards he joined the Osteoporosis Research Group at UCSF
(University of California at San Francisco) under the leadership of Harry
Genant to develop advanced radiographic methods for the diagnosis of
osteoporosis. At UCSF he also developed the first workstation for vertebral
fracture analysis in clinical trials using digitized X-rays. He then joined the
newly formed Institute of Medical Physics (IMP) at the University of Erlangen,
Germany under the leadership of Willi Kalender to develop desktop mCT
scanners and advanced image processing methods. Under his leadership the
IMP also conducted various large and longtime exercise studies to prevent
bone loss in elderly subjects. Prof. Engelke joined Synarc Inc as a Director of
Advanced Imaging Techniques in 2005 and successfully built Synarc’s QCT
services. At the University of Erlangen he continues to develop novel in vivo
and in vitro image acquisition and analysis techniques for the musculoskel-
etal field including rheumatoid and osteoarthritis. He has designed several
phantoms currently used in QCT trials. Prof. Engelke chaired or was member
of the Task Forces of the International Society of Clinical Densitometry
(ISCD) that developed the official positions on the use of QCT in adults and
more recently in children. He co-chaired the Committee on Bone Densitom-
etry of the International Commission on Radiation Units (ICRU) and is a mem-
ber of the committee for the development of the German guidelines for the
diagnosis and treatment of osteoporosis under the auspices of the DVO
‘Dachverband Osteologie’ and a member of the scientific advisory commit-
tee of the International Osteoporosis Foundation (IOF).
HR-pQCT BASED INDIVIDUAL TRABECULA SEGMENTATION (ITS) AND
NONLINEAR FINITE ELEMENT (FE) ANALYSES OF HUMAN DISTAL RADIUS
AND TIBIA
Edward Guo
Columbia University, USA
High-resolution peripheral quantitative computed tomography (HR-pQCT) has
become a widely used clinical imaging modality that provides three dimen-
sional assessments of trabecular and cortical bone microstructure. Based on
the HR-pQCT scans, individual trabecula segmentation (ITS) technique can
further segment the trabecular network into trabecular plates and rods. The
ITS-based morphological assessment technique has been successfully applied
to a variety of clinical studies using HR-pQCT. In addition, HR-pQCT based
finite element (FE) analysis has been used to evaluate bone stiffness, an
important predictor of fracture risk. However, the accuracy of HR-pQCT based
ITS and FE analyses of human distal radius and tibia have not been fully
validated through comparison with gold-standard mCT-based morphological
analyses and direct mechanical testing results.
In this study, 30 distal radius and tibia bone segments corresponding to the
clinical HR-pQCTscan regionwere prepared and imaged by HR-pQCTat clinical
setting (82 mm) and bymicro computed tomography (mCT) at 25 mm resolution.
ITS was applied to the trabecular compartment on both HR-pQCT and mCT
images to evaluate plate and rod related parameters. Uniaxial compression
mechanical test was performed to evaluate mechanical properties of the
segment. HR-pQCT and mCT based nonlinear FE analyses with asymmetric
elastoplastic material property were used to predict stiffness and yield force.
Stiffnesswasdefinedas the slope in the linear region of the force-displacement
curve and yield force was calculated using the 0.2% offset technique.
Among ITS morphological indexes, bone volume fraction (BV/TV), plate bone
volume fraction (pBV/TV) and axial bone volume fraction (aBV/TV) assessed
by HR-pQCT strongly correlated with those by mCT at both radius and tibia (r
> 0.9). Other traditional morphological indexes, such as trabecular thick-
ness, and number and connectivity, showed moderate to strong correlations
between HR-pQCT and mCT (rZ 0.2e0.85). The stiffness and yield force pre-
dicted by HR-pQCT-based FE analysis agree well with direct mechanical
testing measurements and mCT-based nonlinear FE predictions (r > 0.93).In this study, the accuracy of HR-pQCT-based ITS morphological and FE
analyses were thoroughly validated by comparisons with high resolution mCT
and mechanical testing at clinical interest region. The significant correla-
tions provided a quantitative basis for the morphological and mechanical
predictions using HR-pQCT in clinical studies.
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TRABECULAR BONE SCORE (TBS) AND FRAX: FRIENDS OR ENEMIES?
Didier Hans
Center of Bone Diseases, Bone and Joint Department, Lausanne University
Hospital (CHUV), Lausanne, Switzerland
Early accurate estimation of fracture risk, with indicated treatment initiated
promptly, seems to be the best way to reduce the yearly high number of
osteoporotic fractures and associated personal and societal costs. The
problem has been that current guidelines, even combining WHO guidelines
for risk classification using DXA-obtained BMD measurements and the more-
recently-developed WHO FRAX tool, remain suboptimal. It is irrefutable that
altered bone micro-architecture plays a role in the risk of fragility fractures
and is a clinically meaningful component of primary and secondary
osteoporosis. In recent years, a large number of studies have demonstrated
that assessing bone micro-architecture through a novel gray-scale measure-
ment called the TBS not only predicts current and future fragility fractures
in osteoporosis, but also is of value above and beyond the role of BMD and
clinical risk factors (CRF) in fracture detection and prediction, and in the
monitoring of bone health and response to treatment over time.
The FRAX is a diagnostic tool that is used to evaluate a person’s 10-year
probability of a bone fracture integrating. The FRAX integrates CRF and BMD
at the femoral neck to calculate the 10-year probabilities of both a hip
fracture and any major osteoporotic fracture. Leslie et al.(1) assessed
whether TBS provides information on MOF probability beyond that provided
by the FRAX variables in 33,352 women aged 40e100 years (mean 63 years)
with baseline DXA measurements of lumbar spine TBS and femoral neck BMD.
